GGrantIndex
← Search

Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance

$1,984,538N01FY2010AINIH

Ordway Research Institute, Inc., Albany NY

Investigators

Abstract

To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.

View original record on NIH RePORTER →
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance · GrantIndex